The US Food and Drug Administration (FDA) has approved a clear, odorless testosterone gel (Fortesta; Endo Pharmaceuticals) that is applied directly to the front and inner thigh — not the upper body — and rubbed in gently with 1 finger.
The product is indicated to treat hypogonadism, a condition that affects nearly 14 million American men, and will become available in early 2011.
"Declining blood levels of testosterone can occur in men beginning as early as age 40. The symptoms of low
No comments:
Post a Comment